WCLC-话题@MedSci

#WCLC#

72篇内容 | 2587人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1412353, encodeId=b89c1412353de, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC2017]大咖圆桌会（上）：内外、分子病理多视角分享WCLC参会感悟, objectType=article, longId=117656, objectId=cc8211e6562a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc8211e6562a, replyNumber=0, likeNumber=54, createdTime=2017-10-28, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc8211e6562a, moduleTitle=[WCLC2017]大咖圆桌会（上）：内外、分子病理多视角分享WCLC参会感悟, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc8211e6562a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412352, encodeId=63aa14123524b, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】阿帕替尼后线治疗SCLC的疗效再获验证, objectType=article, longId=117310, objectId=80b211e3106f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80b211e3106f, replyNumber=0, likeNumber=69, createdTime=2017-10-25, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80b211e3106f, moduleTitle=【WCLC 2017】阿帕替尼后线治疗SCLC的疗效再获验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80b211e3106f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412351, encodeId=ef461412351b8, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】盘点肺癌治疗的三个“新时代”, objectType=article, longId=117032, objectId=984d11e03292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=984d11e03292, replyNumber=0, likeNumber=67, createdTime=2017-10-22, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=984d11e03292, moduleTitle=【WCLC 2017】盘点肺癌治疗的三个“新时代”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=984d11e03292)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412350, encodeId=9a56141235087, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【IASLC WCLC 2017】听老周讲故事 | 当SCLC遇上免疫治疗, objectType=article, longId=116928, objectId=aa0611692863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa0611692863, replyNumber=0, likeNumber=62, createdTime=2017-10-22, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa0611692863, moduleTitle=【IASLC WCLC 2017】听老周讲故事 | 当SCLC遇上免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa0611692863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412349, encodeId=1017141234951, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC中国之声]支修益教授：中国控烟立法与肺癌早诊早治形势喜人！, objectType=article, longId=116918, objectId=3dc111691897, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dc111691897, replyNumber=0, likeNumber=0, createdTime=2017-10-22, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dc111691897, moduleTitle=[WCLC中国之声]支修益教授：中国控烟立法与肺癌早诊早治形势喜人！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dc111691897)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412348, encodeId=ff8114123480f, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】周彩存教授&吴凤英教授：阿帕替尼在晚期非鳞NSCLC初始治疗进展后持续使用仍然有效, objectType=article, longId=116890, objectId=3e7f116890ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e7f116890ab, replyNumber=0, likeNumber=68, createdTime=2017-10-21, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e7f116890ab, moduleTitle=【WCLC 2017】周彩存教授&吴凤英教授：阿帕替尼在晚期非鳞NSCLC初始治疗进展后持续使用仍然有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e7f116890ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412347, encodeId=418a141234e2f, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】韩宝惠教授解读安罗替尼更新数据：EGFR野生和突变型安罗替尼均获得双阳性结果, objectType=article, longId=116884, objectId=b99c116884cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b99c116884cd, replyNumber=0, likeNumber=82, createdTime=2017-10-21, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b99c116884cd, moduleTitle=【WCLC 2017】韩宝惠教授解读安罗替尼更新数据：EGFR野生和突变型安罗替尼均获得双阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b99c116884cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412346, encodeId=6dd71412346bd, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC精彩研究]支气管镜冲洗液用于EGFR突变检测, objectType=article, longId=116799, objectId=0fa8116e99cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fa8116e99cf, replyNumber=0, likeNumber=62, createdTime=2017-10-21, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fa8116e99cf, moduleTitle=[WCLC精彩研究]支气管镜冲洗液用于EGFR突变检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fa8116e99cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412345, encodeId=c3ca14123458c, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC精彩报告]肺癌患者胸水上清中的肿瘤来源DNA有望用于基于NGS基因突变检测, objectType=article, longId=116798, objectId=9f02116e981b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f02116e981b, replyNumber=0, likeNumber=67, createdTime=2017-10-21, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f02116e981b, moduleTitle=[WCLC精彩报告]肺癌患者胸水上清中的肿瘤来源DNA有望用于基于NGS基因突变检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f02116e981b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412344, encodeId=e02c14123440b, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】NSCLC围手术期动态变化——国际前瞻性研究, objectType=article, longId=116772, objectId=8311116e72ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8311116e72ed, replyNumber=0, likeNumber=65, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8311116e72ed, moduleTitle=【WCLC 2017】NSCLC围手术期动态变化——国际前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8311116e72ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412343, encodeId=b1b61412343c1, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】肺癌靶向辅助捷报频传！王长利教授牵头EVAN研究数据喜人！, objectType=article, longId=116750, objectId=b307116e50ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b307116e50ba, replyNumber=0, likeNumber=79, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b307116e50ba, moduleTitle=【WCLC 2017】肺癌靶向辅助捷报频传！王长利教授牵头EVAN研究数据喜人！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b307116e50ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412342, encodeId=d8251412342db, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】再添新桂|王洁教授团队BENEFIT研究证实液体活检指导一线TKI疗效的可行性, objectType=article, longId=116749, objectId=41a4116e4987, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41a4116e4987, replyNumber=0, likeNumber=92, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41a4116e4987, moduleTitle=【WCLC 2017】再添新桂|王洁教授团队BENEFIT研究证实液体活检指导一线TKI疗效的可行性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41a4116e4987)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412341, encodeId=88111412341a8, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】肺癌大咖铿锵三人行，共话安罗替尼, objectType=article, longId=116747, objectId=1f9e116e475c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f9e116e475c, replyNumber=0, likeNumber=63, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f9e116e475c, moduleTitle=【WCLC 2017】肺癌大咖铿锵三人行，共话安罗替尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f9e116e475c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412340, encodeId=14e8141234009, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】完美落幕，诸多惊喜：吴一龙点评本届WCLC五大亮点, objectType=article, longId=116744, objectId=6ae2116e4494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ae2116e4494, replyNumber=0, likeNumber=74, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ae2116e4494, moduleTitle=【WCLC 2017】完美落幕，诸多惊喜：吴一龙点评本届WCLC五大亮点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ae2116e4494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412339, encodeId=c4a81412339d5, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致, objectType=article, longId=116656, objectId=7181116656ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7181116656ed, replyNumber=0, likeNumber=62, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7181116656ed, moduleTitle=【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7181116656ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412338, encodeId=ed78141233847, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】阿帕替尼再发声，两项研究三度登陆国际大会, objectType=article, longId=116648, objectId=1f79116648c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f79116648c1, replyNumber=0, likeNumber=63, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f79116648c1, moduleTitle=【WCLC 2017】阿帕替尼再发声，两项研究三度登陆国际大会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f79116648c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412337, encodeId=2274141233e40, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC2017]肺癌外科治疗领域亮点璀璨，北京大学肿瘤医院康晓征研究报告闪耀其中, objectType=article, longId=116646, objectId=9230116646db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9230116646db, replyNumber=0, likeNumber=91, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9230116646db, moduleTitle=[WCLC2017]肺癌外科治疗领域亮点璀璨，北京大学肿瘤医院康晓征研究报告闪耀其中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9230116646db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412336, encodeId=a976141233623, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC2017突出进展有哪些？且听往届大会主席Robert Pirker教授如何说, objectType=article, longId=116644, objectId=406c11664404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=406c11664404, replyNumber=0, likeNumber=64, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=406c11664404, moduleTitle=WCLC2017突出进展有哪些？且听往届大会主席Robert Pirker教授如何说, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=406c11664404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412335, encodeId=b08b1412335e5, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC中国专场]徐建青教授解读免疫治疗，细胞免疫治疗有望缓解晚期肺癌疾病进展, objectType=article, longId=116643, objectId=028711664383, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=028711664383, replyNumber=0, likeNumber=64, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=028711664383, moduleTitle=[WCLC中国专场]徐建青教授解读免疫治疗，细胞免疫治疗有望缓解晚期肺癌疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=028711664383)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412334, encodeId=c0b1141233480, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC2017]胡洁教授深入解读ctDNA检测肿瘤突变负荷（TMB）在中国肺癌免疫治疗中的应用, objectType=article, longId=116642, objectId=d179116642cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d179116642cc, replyNumber=0, likeNumber=83, createdTime=2017-10-20, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d179116642cc, moduleTitle=[WCLC2017]胡洁教授深入解读ctDNA检测肿瘤突变负荷（TMB）在中国肺癌免疫治疗中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d179116642cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

WCLC

2020-05-29

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC2017]大咖圆桌会（上）：内外、分子病理多视角分享WCLC参会感悟

2017-10-28

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】阿帕替尼后线治疗SCLC的疗效再获验证

2017-10-25

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】盘点肺癌治疗的三个“新时代”

2017-10-22

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【IASLC WCLC 2017】听老周讲故事 | 当SCLC遇上免疫治疗

2017-10-22

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC中国之声]支修益教授：中国控烟立法与肺癌早诊早治形势喜人！

2017-10-22

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】周彩存教授&吴凤英教授：阿帕替尼在晚期非鳞NSCLC初始治疗进展后持续使用仍然有效

2017-10-21

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】韩宝惠教授解读安罗替尼更新数据：EGFR野生和突变型安罗替尼均获得双阳性结果

2017-10-21

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC精彩研究]支气管镜冲洗液用于EGFR突变检测

2017-10-21

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC精彩报告]肺癌患者胸水上清中的肿瘤来源DNA有望用于基于NGS基因突变检测

2017-10-21

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】NSCLC围手术期动态变化——国际前瞻性研究

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】肺癌靶向辅助捷报频传！王长利教授牵头EVAN研究数据喜人！

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】再添新桂|王洁教授团队BENEFIT研究证实液体活检指导一线TKI疗效的可行性

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】肺癌大咖铿锵三人行，共话安罗替尼

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】完美落幕，诸多惊喜：吴一龙点评本届WCLC五大亮点

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】阿帕替尼再发声，两项研究三度登陆国际大会

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC2017]肺癌外科治疗领域亮点璀璨，北京大学肿瘤医院康晓征研究报告闪耀其中

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC2017突出进展有哪些？且听往届大会主席Robert Pirker教授如何说

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC中国专场]徐建青教授解读免疫治疗，细胞免疫治疗有望缓解晚期肺癌疾病进展

2017-10-20

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC2017]胡洁教授深入解读ctDNA检测肿瘤突变负荷（TMB）在中国肺癌免疫治疗中的应用

2017-10-20

科室
- - 订阅+
  - 更多科室
工具
服务